Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Operations

v3.22.1
Condensed Statements of Operations - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]    
Revenue $ 215,961 $ 145,065
Costs and expenses:    
Cost of revenue 203,249  
Research and development 3,527,146 4,591,244
Sales and marketing 1,613,590 1,794,212
General and administrative 2,027,520 2,287,396
Total costs and expenses 7,371,505 8,672,852
Loss from operations (7,155,544) (8,527,787)
Other income:    
Interest income 2,826 2,024
Total other income 2,826 2,024
Net loss $ (7,152,718) $ (8,525,763)
Basic and diluted loss per common share $ (0.09) $ (0.14)
Weighted average shares outstanding, basic and diluted 76,930,919 61,567,003